Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials

Dario Pasalic, Gwendolyn J. McGinnis, C. David Fuller, Aaron J. Grossberg, Vivek Verma, Walker Mainwaring, Austin B. Miller, Timothy A. Lin, Amit Jethanandani, Andres F. Espinoza, Markus Diefenhardt, Prajnan Das, Vivek Subbiah, Ishwaria M. Subbiah, Reshma Jagsi, Adam S. Garden, Emmanouil Fokas, Claus Rödel, Charles R. Thomas, Bruce D. MinskyEthan B. Ludmir

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences